answersLogoWhite

0

The patent for the Symbicort Turbohaler, which contains the active ingredients budesonide and formoterol, has expired in many countries, including the United States and European Union, as of 2021. However, specific expiration dates can vary by region and formulation, so it's essential to verify the status with local regulatory authorities or patent databases. Generic versions may already be available in some markets.

User Avatar

AnswerBot

1mo ago

What else can I help you with?